Results 101 to 110 of about 7,633 (200)

Endoscopic and clinicopathological features of segmental colitis associated with diverticulosis

open access: yesDEN Open
Objectives Segmental colitis associated with diverticulosis (SCAD) has close endoscopic and pathological similarities to ulcerative colitis (UC) and Crohn's disease. Clinical data on SCAD are limited in Japan.
Kazuhiko Obata   +2 more
doaj   +1 more source

Innovative Rectal Suspension of Mesalamine Utilizing Mesoporous Silica for Sustained and Colon-Specific Drug Delivery : Novel rectal suspension of mesalamine

open access: yes
Mesalamine is an anti-inflammatory drug for the treatment of ulcerative colitis-related colon cancer. The present study aims to evaluate the rectal suspension of mesoporous mesalamine for improved localized effect of the drug in the ulcerative colon of ...
Prajapati, Rajnish Umesh   +2 more
core   +1 more source

Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence

open access: yes, 2000
: Mesalamine-induced lung toxicity has often been described. We report on a case of a patient who underwent mesalamine treatment, though in the absence of established criteria required for diagnosing Crohn's disease (CD) or ulcerative colitis (UC).
Trisolini, R
core   +1 more source

Design, development and in vitro evaluation of Mesalamine tablets containing Pectin and Chitosan for colon-specific drug delivery

open access: yesInternational Journal of Research in Pharmaceutical Sciences, 2010
The potential of matrix, multilayer and compression coated tablets of Mesalamine to reach the colon intact has been investigated in vitro, using Pectin as a carrier. Matrix tablets containing various proportions of Pectin were prepared by wet granulation
Nirav V. Patel   +3 more
doaj  

Mesalamine: Safe at first look [PDF]

open access: yesInflammatory Bowel Diseases, 1999
L J, Saubermann, J L, Wolf
openaire   +2 more sources

CODEN: RJCABP LARGE SCALE PROCESS OF MESALAMINE GREEN APPROACH FOR LARGE SCALE PROCESS OF MESALAMINE: AN ANTI INFLAMMATORY AGENT

open access: yes, 2009
Mesalamine 1 is as an anti inflammatory agent in treating ulcerative colitis and crohn's disease. Its benefit is believed to be due to a topical effect on the inflamed bowel.
Jaydeepkumar Lilakar, Neti Srinivasan
core  

Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial

open access: yes, 2008
Sunanda Kane1, William Holderman2, Peter Jacques2, Todd Miodek31Mayo Clinic College of Medicine, Rochester, MN, USA; 2Digestive Health Specialists, Tacoma, WA, USA; 3University of Chicago, Chicago, IL, USABackground and Aims: Multiple studies have ...
Sunanda Kane   +3 more
core  

Mesalamine Microemulsions for Crohn’s Disease: A Review [PDF]

open access: yes
oai:ojs.ijhse.com:article/1This analysis delves into the promise of mesalamineencapsulated microemulsions in improving bioavailability and therapeutic effectiveness for Crohn\u27s disease. Crohn’s disease, a persistent inflammatory condition of the bowel,
Subham Mandal, Suraj Mandal
core   +1 more source

Eosinophilic pleural effusion due to mesalamine. Report of a rare occurence

open access: yes, 2000
Mesalamine-induced lung toxicity has often been described. We report on a case of a patient who underwent mesalamine treatment, though in the absence of established criteria required for diagnosing Crohn's diseases (CD) or ulcerative colitis (UC).
Trisolini R.   +6 more
core  

Home - About - Disclaimer - Privacy